iifl-logo

Kilitch Drugs (India) Ltd Share Price Live

₹445
(0.91%)
Aug 1, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹449.75
  • Day's High₹449.75
  • 52 Wk High₹500
  • Prev. Close₹441
  • Day's Low₹441.2
  • 52 Wk Low ₹293.53
  • Turnover (lac)11.33
  • P/E24.97
  • Face Value₹10
  • Book Value₹173.91
  • EPS17.82
  • Mkt. Cap (Cr.)₹777.89
  • Div. Yield0
View All Historical Data
No Records Found

Kilitch Drugs (India) Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹449.75

Prev. Close

₹441

Turnover(Lac.)

₹11.33

Day's High

₹449.75

Day's Low

₹441.2

52 Week's High

₹500

52 Week's Low

₹293.53

Book Value

₹173.91

Face Value

₹10

Mkt Cap (₹ Cr.)

777.89

P/E

24.97

EPS

17.82

Divi. Yield

0

Kilitch Drugs (India) Ltd Corporate Action

26 Aug 2024

12:00 AM

BookCloser

arrow

26 Aug 2024

12:00 AM

AGM

Announcement Date: 26 Aug, 2024

arrow

12 Jul 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

9 Jul 2025

12:00 AM

Rights

arrow

Kilitch Drugs (India) Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Kilitch Drugs (India) Ltd SHAREHOLDING SNAPSHOT

03 Aug, 2025|05:50 PM
Jun-2025Mar-2025Dec-2024Sep-2024
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 69.23%

Foreign: 0.00%

Indian: 69.23%

Non-Promoter- 0.00%

Institutions: 0.00%

Non-Institutions: 30.76%

Custodian: 0.00%

Read More
Share Price

Kilitch Drugs (India) Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

16.08

20.58

18.08

15.49

Preference Capital

0

0

0

0

Reserves

206.84

175.35

159.95

147.44

Net Worth

222.92

195.93

178.03

162.93

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

70.01

60.76

96.41

50.45

yoy growth (%)

15.21

-36.97

91.08

79.31

Raw materials

-39.06

-35.75

-52.98

-25.9

As % of sales

55.79

58.83

54.95

51.34

Employee costs

-5.21

-5.65

-5.22

-4.21

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

7.5

5.22

19.52

7.15

Depreciation

-1.14

-1.15

-1.2

-1.19

Tax paid

-1.35

-0.76

-4.75

-0.96

Working capital

-1.1

-5.99

6.43

6.49

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

15.21

-36.97

91.08

79.31

Op profit growth

276.91

-91.66

197.85

-2,095.55

EBIT growth

39.14

-70.16

178.12

-1,655.73

Net profit growth

38.1

-69.81

138.33

-17,121.7

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

198.32

154.37

139.6

114.23

68.52

Excise Duty

0

0

0

0

0

Net Sales

198.32

154.37

139.6

114.23

68.52

Other Operating Income

0

0

0

0

0

Other Income

11.16

4.48

2.92

2.91

2.67

View Annually Results

Kilitch Drugs (India) Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,706.7

95.714,09,218.58753.530.945,566.68101.44

Divis Laboratories Ltd

DIVISLAB

6,595.5

79.351,75,226.526670.452,536561.08

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,741.9

63.71,26,637.215510.162,567224.34

Cipla Ltd

CIPLA

1,554.6

24.31,25,540.691,303.131.034,501.66397.39

Dr Reddys Laboratories Ltd

DRREDDY

1,270.3

15.391,06,062.832,961.20.637,788.7345.76

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Kilitch Drugs (India) Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Mukund P Mehta

Whole-time Director

Bhavin M Mehta

Independent Director

Hemang Engineer

Managing Director

Mira Bhavin Mehta

Independent Director

Murti Vasudev Krishna

Independent Director

Venkita Subramanian Rajan

Company Sec. & Compli. Officer

Pushpa Nyoupane

Independent Director

Dipen Jayantilal Jain

Registered Office

C-301/2 MIDC TTC Indl Area,

Pawane Village,

Maharashtra - 400705

Tel: 91-022-27670322/27680913/65144185

Website: http://www.kilitch.com

Email: info@kilitch.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: www.linkintime.co.in

Email: paytm.ipo@linkintime.co.in

Summary

Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range ...
Read More

Reports by Kilitch Drugs (India) Ltd

Company FAQs

What is the Kilitch Drugs India Ltd share price today?

The Kilitch Drugs India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹445 today.

What is the Market Cap of Kilitch Drugs India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kilitch Drugs India Ltd is ₹777.89 Cr. as of 01 Aug ‘25

What is the PE and PB ratio of Kilitch Drugs India Ltd?

The PE and PB ratios of Kilitch Drugs India Ltd is 24.97 and 2.57 as of 01 Aug ‘25

What is the 52 Week High and Low of Kilitch Drugs India Ltd?

The 52-week high/low is the highest and lowest price at which a Kilitch Drugs India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kilitch Drugs India Ltd is ₹293.53 and ₹500 as of 01 Aug ‘25

What is the CAGR of Kilitch Drugs India Ltd?

Kilitch Drugs India Ltd's CAGR for 5 Years at 39.27%, 3 Years at 40.14%, 1 Year at 20.45%, 6 Month at 43.61%, 3 Month at 11.92% and 1 Month at 1.95%.

What is the shareholding pattern of Kilitch Drugs India Ltd?

The shareholding pattern of Kilitch Drugs India Ltd is as follows:
Promoters - 69.23 %
Institutions - 0.00 %
Public - 30.76 %

QUICKLINKS FOR Kilitch Drugs (India) Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Loans
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.